Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis (Q33818183)

29 July 2017

1 reference

title

Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis (English)

1 reference

ORCID Public Data File 2021

29 July 2017

main subject

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

1 reference

author name string

J Eskola

1

1 reference

29 July 2017

J Ward

2

1 reference

29 July 2017

R Dagan

3

1 reference

29 July 2017

D Goldblatt

4

1 reference

29 July 2017

F Zepp

5

1 reference

29 July 2017

C A Siegrist

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

354

1 reference

29 July 2017

issue

9195

1 reference

29 July 2017

page(s)

2063-2068

1 reference

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Immunological response to conjugate vaccines in infants: follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Interactions between PRP-T vaccine against Haemophilus influenzae type b and conventional infant vaccines. Lessons for future studies of simultaneous immunization and combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzas type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Conjugate vaccines and the carriage of Haemophilus influenzae type b.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

The impact of Haemophilus influenzae type b vaccination in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904377-9

7 January 2021

10.1016/S0140-6736(99)04377-9

Identifiers

DOI

1 reference

29 July 2017

1 reference